These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10321972)

  • 1. p53 and the CNS: tumors and developmental abnormalities.
    Fulci G; Van Meir EG
    Mol Neurobiol; 1999 Feb; 19(1):61-77. PubMed ID: 10321972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the TP73 gene and its transcripts in neuro-oncology.
    Jancalek R
    Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tumor suppressor p53 and DNA viruses.
    Collot-Teixeira S; Bass J; Denis F; Ranger-Rogez S
    Rev Med Virol; 2004; 14(5):301-19. PubMed ID: 15334538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.
    Holmberg Olausson K; Maire CL; Haidar S; Ling J; Learner E; Nistér M; Ligon KL
    PLoS One; 2014; 9(9):e106694. PubMed ID: 25184684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of rRNA synthesis in the bap28 mutation leads to apoptosis mediated by p53 in the zebrafish central nervous system.
    Azuma M; Toyama R; Laver E; Dawid IB
    J Biol Chem; 2006 May; 281(19):13309-13316. PubMed ID: 16531401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
    Karamitopoulou E; Perentes E; Diamantis I
    Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.
    Kapoor GS; Christie A; O'Rourke DM
    Cancer Biol Ther; 2007 Apr; 6(4):571-9. PubMed ID: 17457042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cell proliferation, apoptosis, and DNA-repair genes as potential biomarkers for ethanol-induced CNS alterations.
    Hicks SD; Lewis L; Ritchie J; Burke P; Abdul-Malak Y; Adackapara N; Canfield K; Shwarts E; Gentile K; Meszaros ZS; Middleton FA
    BMC Neurosci; 2012 Oct; 13():128. PubMed ID: 23095216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.
    Senatus PB; Li Y; Mandigo C; Nichols G; Moise G; Mao Y; Brown MD; Anderson RC; Parsa AT; Brandt-Rauf PW; Bruce JN; Fine RL
    Mol Cancer Ther; 2006 Jan; 5(1):20-8. PubMed ID: 16432159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T; Miller DC; Hayes RL; Alonso M; Yee H; Newcomb EW
    Brain Pathol; 2000 Apr; 10(2):249-59. PubMed ID: 10764044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.
    Macleod KF; Hu Y; Jacks T
    EMBO J; 1996 Nov; 15(22):6178-88. PubMed ID: 8947040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas.
    Bello MJ; Rey JA
    Cancer Genet Cytogenet; 2006 Jan; 164(2):172-3. PubMed ID: 16434325
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular genetic characterization of CNS tumor oncogenesis.
    James CD; Collins VP
    Adv Cancer Res; 1992; 58():121-42. PubMed ID: 1347671
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
    Xiong S; Van Pelt CS; Elizondo-Fraire AC; Liu G; Lozano G
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3226-31. PubMed ID: 16492743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
    Yu BX; Zou L; Li S; Du YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in p53 research and cancer treatment.
    Suzuki K; Matsubara H
    J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic analysis of central nervous system development and regeneration.
    Lendahl U
    Acta Anaesthesiol Scand Suppl; 1997; 110():116-8. PubMed ID: 9248556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system.
    Deckert-Schlüter M; Rang A; Wiestler OD
    Acta Neuropathol; 1998 Aug; 96(2):157-62. PubMed ID: 9705131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.